Key result
Minimally invasive implantation of a HeartMate II device in a 64-year-old man was complicated by pump thrombosis, stroke, and multiple infections, leading to death after 8 months.
Case Report (n=1)
Minimally invasive approaches for left ventricular assist device implantation are feasible but can still be associated with serious complications.
Answers are grounded in this paper and cite their sources.
Serious complications can occur with minimally invasive LVAD implantation; leaves open questions on technique safety versus standard approaches.
Ventricular assistance concerns patients with advanced cardiac failure in whom maximal medical and surgical treatment has been used. The ventricular assistance has two main purposes: first, to maintain circulation by discharging the ventricle (s) to provide recovery, and second to ensure patient survival by replacing cardiac function permanently or transitionally for patients waiting for cardiac Transplantation. The encouraging results of the partial or total artificial heart and the miniaturization of these devices allow their use in permanent implantation for patients with cardiac insufficiency that is not eligible for transplantation. In left mono-ventricular assistance, blood is taken from a cannula placed at the apex of the left ventricle (LV) and returned to the patient by an anastomosed vascular prosthesis with the ascending aorta. The classic surgical approach is a total median sternotomy. Other minimally invasive approaches for the implantation or explanation of left ventricular assist devices have been published and have shown encouraging results. These alternatives currently play an important role in certain indications and in patients with heavy medical history. Nevertheless, the complications of the ventricular assistance even by minimally invasive approaches might be serious and represent a turning point in the life of the patients. We describe the implantation of a left ventricular assistance using HeartMate II device by left under costal and high mini sternotomy approach in a tridux patient with permeable coronary bypasses and we discuss its postoperative evolution.
No takes yet. Share an insight, caveat, or question.
Mleyhi et al. (2017) conducted a case report in Advanced heart failure (n=1). Minimally invasive implantation of HeartMate II left ventricular assist device was evaluated. Minimally invasive implantation of a HeartMate II device in a 64-year-old man was complicated by pump thrombosis, stroke, and multiple infections, leading to death after 8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: